|Articles|October 26, 2010

Sempermed USA, Inc. Awarded Contract to Manufacture NOVAPLUS Exam Gloves

Sempermed USA, Inc., a leading manufacturer and supplier of hand protection, announces it has been awarded an agreement as the sole source manufacturer for Novations NOVAPLUS® Exam Glove line.

Novation, one of the healthcare industry's leading supply contracting companies, stated that Sempermed was rated among the highest for acceptability by their Clinical and Supply Council and that was a key factor in the selection process.

Beginning Jan.  1, 2011, the NOVAPLUS contract with Sempermed will offer the members of VHA, University HealthSystem Consortium (UHC) and Provista a complete line of quality nitrile, vinyl and latex examination gloves.

NOVAPLUS, Novations private label brand of pharmacy and medical-surgical products, delivers the best financial value for VHA, UHC and Provista members on the most frequently-purchased commodity products. Originally founded in 1985 as VHAPLUS, the private label currently includes more than 1,100 products with annual purchases of $1.6 billion.


Related to this article

Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
A brightly lit Hospital operating room, a surgical team wearing gowns and masks.  (Adobe Stock 1790696595 by Damian)
Turnover pressure can leave critical OR cleaning steps unfinished. Karen deKay, MSN, RN, EBP-C, CNOR, CIC, FAPIC, examines common gaps in environmental hygiene and how shared responsibilities, attention to disinfectant contact time, and ongoing education can help teams strengthen practices between cases.
Infection preventionists in full PPE with children in DRC.  (Image credit: author with AI)
Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.